gliclazide has been researched along with Testicular Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harris, AL; Hong, X; Tao, L; Tong, X; Wang, Q; Yang, Y; Zhang, S; Zheng, S | 1 |
1 other study(ies) available for gliclazide and Testicular Neoplasms
Article | Year |
---|---|
Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Communication; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Connexin 43; Gap Junctions; Glycyrrhetinic Acid; Leydig Cells; Male; Mice; RNA Interference; Sertoli Cells; Testicular Neoplasms; Testis | 2012 |